These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 12603971)

  • 1. Breast cancer: non-metastatic.
    Dixon JM; Gregory K; Johnston S; Rodger A
    Clin Evid; 2002 Dec; (8):1811-39. PubMed ID: 12603971
    [No Abstract]   [Full Text] [Related]  

  • 2. Breast cancer: non-metastatic.
    Dixon JM; Gregory K; Johnston S; Rodger A
    Clin Evid; 2002 Jun; (7):1603-30. PubMed ID: 12230775
    [No Abstract]   [Full Text] [Related]  

  • 3. [Breast cancer treatment].
    Duodecim; 2005; 121(3):317-8. PubMed ID: 15787290
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical and morphologic features and methods of treatment of non-invasive breast cancer].
    Semiglazov VV; Semiglazov VF
    Vopr Onkol; 2001; 47(3):278-89. PubMed ID: 11544824
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
    Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
    Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives on preoperative staging with breast MRI.
    Hollingsworth AB
    J Am Coll Surg; 2004 Jul; 199(1):173-4. PubMed ID: 15217651
    [No Abstract]   [Full Text] [Related]  

  • 7. [1st revision of the National Consensus on Breast Cancer Treatment].
    Consenso Nacional sobre Tratamiento del Cáncer Mamario
    Ginecol Obstet Mex; 2002 Jul; 70():349-60. PubMed ID: 12221911
    [No Abstract]   [Full Text] [Related]  

  • 8. Ductal carcinoma in situ (DCIS). A highly treatable breast cancer.
    Mayo Clin Womens Healthsource; 2009 Oct; 13(10):1-2. PubMed ID: 19727033
    [No Abstract]   [Full Text] [Related]  

  • 9. Surveillance, Epidemiology, and End Results program underestimates breast cancer-specific mortality after ductal carcinoma in situ diagnosis.
    O'Keefe TJ; Wallace AM
    Breast Cancer Res Treat; 2020 Aug; 182(3):761-762. PubMed ID: 32529407
    [No Abstract]   [Full Text] [Related]  

  • 10. Current management of primary breast cancer. Part II: Adjuvant therapy and management of stage III disease and in-situ carcinoma.
    Lopez MJ; Andriole DP
    Mo Med; 1990 Oct; 87(10):757-62. PubMed ID: 2175383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Limitations of sentinel lymph node biopsy in breast cancer].
    Fehr MK
    Gynakol Geburtshilfliche Rundsch; 2005 Jun; 45(3):127-31. PubMed ID: 15990436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Guidelines for treatment of breast carcinoma by the Gynecological Oncology Working Group. Gynecological Oncology Working Group].
    Concin H; Grünberger W; Kubista E; Menzel C; Pickel H; Reiner A; Seitz W; Sevelda P; Staudach A; Widschwendter M; Wolf G
    Gynakol Geburtshilfliche Rundsch; 1999; 39(4):226-9. PubMed ID: 10629389
    [No Abstract]   [Full Text] [Related]  

  • 13. [A practice guideline for diagnosis and treatment of ductal in situ carcinoma of the breast].
    Delaloye JF; Wight E; Fink D; Otto R; Steiner R;
    Gynakol Geburtshilfliche Rundsch; 2006; 46(1-2):64-7. PubMed ID: 16452823
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system.
    Hudis CA; Barlow WE; Costantino JP; Gray RJ; Pritchard KI; Chapman JA; Sparano JA; Hunsberger S; Enos RA; Gelber RD; Zujewski JA
    J Clin Oncol; 2007 May; 25(15):2127-32. PubMed ID: 17513820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The importance of determining androgen receptors in malignant breast tumors].
    Gershteĭn ES; Smirnova KD; Vishniakova VV; Ermilova VD
    Vopr Onkol; 1988; 34(12):1460-4. PubMed ID: 2851214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for local recurrence in patients with invasive breast cancer and negative surgical margins of excision. Where are we and where are we going?
    Schnitt SJ
    Am J Clin Pathol; 2003 Oct; 120(4):485-8. PubMed ID: 14560560
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of early-stage breast cancer.
    Curr Probl Cancer; 1999; 23(4):149-228. PubMed ID: 10485445
    [No Abstract]   [Full Text] [Related]  

  • 19. [Interdisciplinary communication in breast-preserving therapy of early infiltrating ductal breast carcinoma].
    Greiner R; Kenesei G
    Schweiz Rundsch Med Prax; 1991 Mar; 80(11):262-8. PubMed ID: 1850870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NCCN: Breast cancer.
    Carlson RW; Edge SB; Theriault RL;
    Cancer Control; 2001; 8(6 Suppl 2):54-61. PubMed ID: 11760559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.